Long -Term Outcomes of Liver Transplantation in Patients With Pretransplant Renal Dysfunction Treated With Induction Therapy and Delayed Reduced De Novo Once -Daily Tacrolimus

被引:0
|
作者
Gastaca, Mikel [1 ,3 ]
Prieto, Mikel [1 ,3 ]
Palomares, Ibone [1 ]
Bustamante, Javier [2 ]
Fernandez, Jose R. [2 ]
Ruiz, Patricia [1 ]
Ventoso, Alberto [1 ]
Salvador, Patricia [2 ]
Senosiain, Maria [2 ]
Testillano, Milagros [2 ]
Suarez, Maria J. [2 ]
Valdivieso, Andres [1 ,3 ]
机构
[1] Hosp Univ Cruces, Biocruces Bizkaia Hlth Res Inst, Hepatobiliary Surg & Liver Transplantat Unit, Bilbao, Spain
[2] Hosp Univ Cruces, Biocruces Bizkaia Hlth Res Inst, Hepatol Unit, Bilbao, Spain
[3] Univ Basque Country, Med Dept, Bilbao, Spain
关键词
KIDNEY-TRANSPLANTATION; MYCOPHENOLATE-MOFETIL; RECIPIENTS; MONOTHERAPY; IMMUNOSUPPRESSION; MORTALITY; EFFICACY; FAILURE; DISEASE;
D O I
暂无
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
引用
收藏
页码:1489 / 1492
页数:4
相关论文
共 50 条
  • [21] Obesity in Renal Transplantation: The Role of Induction Therapy on Long-Term Outcomes
    Patel, S.
    Pankewycz, O.
    Kohli, R.
    Said, M.
    Alnimri, M.
    Feng, L.
    Laftavi, M. R.
    TRANSPLANTATION PROCEEDINGS, 2011, 43 (02) : 469 - 471
  • [23] Long-lasting renal dysfunction following tacrolimus induction therapy in ulcerative colitis patients
    Cha, Na
    Oshima, Naoki
    Kishimoto, Kenichi
    Kotani, Satoshi
    Okimoto, Eiko
    Yazaki, Tomotaka
    Sonoyama, Hiroki
    Oka, Akihiko
    Mishima, Yoshiyuki
    Shibagaki, Kotaro
    Tobita, Hiroshi
    Kawashima, Kousaku
    Ishimura, Norihisa
    Ishihara, Shunji
    JOURNAL OF CLINICAL BIOCHEMISTRY AND NUTRITION, 2022, 70 (03) : 297 - 303
  • [24] Recurrent or De Novo Allograft Steatosis and Long-term Outcomes After Liver Transplantation
    Narayanan, Praveena
    Mara, Kristin
    Izzy, Manhal
    Dierkhising, Ross
    Heimbach, Julie
    Allen, Alina M.
    Watt, Kymberly D.
    TRANSPLANTATION, 2019, 103 (01) : e14 - e21
  • [25] LONG-TERM OUTCOMES OF DE NOVO MALIGNANCY AFTER LIVER TRANSPLANTATION FOR ALCOHOLIC CIRRHOSIS
    Pascale, Marco Maria
    Nure, Erida
    Bianco, Giuseppe
    Frongillo, Francesco
    Agnes, Salvatore
    TRANSPLANT INTERNATIONAL, 2021, 34 : 333 - 334
  • [26] SAFE ONCE-DAILY TACROLIMUS CONVERSION FROM TWICE-DAILY TACROLIMUS IN LONG-TERM STABLE PEDIATRIC RECIPIENTS AFTER LIVER TRANSPLANTATION.
    Lee, N.
    Lee, S.
    Joh, J-W
    Lee, S-K
    PEDIATRIC TRANSPLANTATION, 2017, 21 : 77 - 77
  • [27] Comparative analysis of delayed tacrolimus immunosuppression, +/- antibody induction, in orthotopic liver transplant patients with preoperative renal dysfunction
    Johnson, M
    Salm, J
    McIver, P
    Dupuis, R
    Conoley, R
    Shrestha, R
    Zacks, S
    Gerber, D
    Fair, J
    Andreoni, K
    AMERICAN JOURNAL OF TRANSPLANTATION, 2004, 4 : 363 - 363
  • [28] Renal function after liver transplantation: Real-world experience with basiliximab induction and delayed reduced-dose tacrolimus
    Cederborg, Anna
    Noren, Asa
    Barten, Thijs
    Lindkvist, Bjorn
    Bennet, William
    Herlenius, Gustaf
    Castedal, Maria
    Marschall, Hanns-Ulrich
    Aberg, Fredrik
    DIGESTIVE AND LIVER DISEASE, 2022, 54 (08) : 1076 - 1083
  • [29] INDUCTION THERAPY WITH BASILIXIMAB AND DELAYED INTRODUCTION OF TACROLIMUS IS ASSOCIATED WITH A REDUCED REQUIREMENT FOR POST-OPERATIVE RENAL REPLACEMENT THERAPY IN HIGH-RISK PATIENTS UNDERGOING ORTHOTOPIC LIVER TRANSPLANTATION (OLT)
    Adair, A.
    Hamid, R.
    Bathgate, A.
    Powell, J. J.
    TRANSPLANT INTERNATIONAL, 2011, 24 : 198 - 198
  • [30] Long-term results of tacrolimus therapy for renal transplantation in patients with diabetic nephropathy in Japan
    Sugitani, A
    Tanaka, M
    Takahara, S
    Uchida, K
    Yoshimura, N
    Takahashi, K
    Toma, H
    Oshima, S
    Sonoda, T
    TRANSPLANTATION PROCEEDINGS, 2005, 37 (04) : 1767 - 1768